VALENCIA, Calif.--(BUSINESS WIRE)--Advanced Bionics (AB), a global leader in cochlear implant technology and a company of the Sonova Group, announced today that the Naída CI Q30 and Q90 sound processors* have been approved by the Food and Drug Administration for distribution in the United States. FDA approval follows Health Canada approval earlier this year. Wide distribution of the Naída CI Q90 in the United States and Canada is planned to take place later this year. The Naída CI Q30 is design